http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0033653-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f96dc90895e0468bcf6776ba3b47de1
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N1-0247
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B01D17-038
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A01N1-00
filingDate 1999-12-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2da1a614b9424c92b89865194f9ef450
publicationDate 2000-06-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-0033653-A1
titleOfInvention Cryopreservation and recovery of blood components
abstract A system dynamically adjusts the delivery rate of a cryopreservation solution to red blood cells to permit freezing. The delivery rate is preferably determined according to an equation that maintains a linear change of red blood cell osmolarity over time so as to prevent osmolarity shock of the red blood cells. In the preferred embodiment, the system includes a controller that is preconfigured to automatically deliver the cryopreservation solution to the red blood cells in accordance with the equation. The system may also support the recovery of thawed red blood cells by diluting the red blood cells and washing them of the cryopreservative. Again, the system preferably adjusts the delivery rate of a dilution solution so as to prevent osmolarity shock of the red blood cells during the recovery phase. The recovered red blood cells may be suspended in a preservation solution to further increase their shelf-life following the recovery phase.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10806139-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3101119-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-10117205-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8895236-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9833794-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-169287-U1
priorityDate 1998-12-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-RE33924-E
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9532624-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CA-2259878-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9908513-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512635
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID962

Total number of triples: 26.